Panitumumab and Gemcitabine in Relapsed Ovarian Cancer

NCT01296035 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

8

Enrollment

OTHER

Sponsor class

Stopped Newer technologies available; poor accrual to study.

Conditions

Ovarian Cancer
Fallopian Tube Cancer
Primary Peritoneal Cancer

Interventions

BIOLOGICAL: Panitumumab

Sponsor

Women and Infants Hospital of Rhode Island

Collaborators

[object Object]